COPD Trial, Recruiting (NCT06652204)

COPD Trial, Recruiting NCT06652204 Sponsor: University Hospital, Brest Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06652204 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be a caregiver for a family member who has been diagnosed with COPD (a chronic lung disease).
You must be 18 years old or older.
The person you care for must currently be in a stable condition, meaning they have not had a flare-up or worsening of their COPD in the past month.
You must be a family member of the person you care for, or live in the same home as them.
You must be able to read and complete questionnaires written in French.
You must provide a statement saying you do not object to taking part in the study.

Who may not be able to join:

People who are under a legal protection order, such as guardianship or curatorship (confirm with trial site).
Anyone who does not wish to take part in the study.
Caregivers whose loved one has had a flare-up or worsening of their COPD within the last month.
Caregivers who report that the person they care for has memory or thinking difficulties (cognitive impairments).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Beaumont, PhD, Centre Hospitalier des Pays de Morlaix

Phone: +33 298626160

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06652204

Sponsor: University Hospital, Brest

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: +33 298626160

More information: https://clinicaltrials.gov/study/NCT06652204

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be a caregiver for a family member who has been diagnosed with COPD (a chronic lung disease).
You must be 18 years old or older.
The person you care for must currently be in a stable condition, meaning they have not had a flare-up or worsening of their COPD in the past month.
You must be a family member of the person you care for, or live in the same home as them.
You must be able to read and complete questionnaires written in French.
You must provide a statement saying you do not object to taking part in the study.

Who may not be able to join:

People who are under a legal protection order, such as guardianship or curatorship (confirm with trial site).
Anyone who does not wish to take part in the study.
Caregivers whose loved one has had a flare-up or worsening of their COPD within the last month.
Caregivers who report that the person they care for has memory or thinking difficulties (cognitive impairments).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Brest

Registry

ClinicalTrials.gov

Start date

22 October 2024

Est. completion

15 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Validation of the translation of the long version of the QASCI questionnaire (measuring caregiver burden) from Portuguese to French after the translation-back translation stage.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov